These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 15555337)
21. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908 [TBL] [Abstract][Full Text] [Related]
22. [Expression of VEGF in prostate cancer and its correlation with ET-1]. Zhou WQ; Yin HL; Zhang ZY; Yi XM; Ge JP; Zhou SG; Cheng W; Wei W; Ma HQ; Ma HH; Gao JP Zhonghua Nan Ke Xue; 2008 Nov; 14(11):987-92. PubMed ID: 19102498 [TBL] [Abstract][Full Text] [Related]
23. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018 [TBL] [Abstract][Full Text] [Related]
24. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850 [TBL] [Abstract][Full Text] [Related]
25. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z; Liu J; Li S; Shen W Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463 [TBL] [Abstract][Full Text] [Related]
26. Expression of c-jun oncogene in hyperplastic and carcinomatous human prostate. Tiniakos DG; Mitropoulos D; Kyroudi-Voulgari A; Soura K; Kittas C Urology; 2006 Jan; 67(1):204-8. PubMed ID: 16413376 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance of the leptin and leptin receptor expressions in prostate tissues. Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356 [TBL] [Abstract][Full Text] [Related]
28. Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue. Du Z; Fujiyama C; Chen Y; Masaki Z Chin Med J (Engl); 2003 Dec; 116(12):1936-9. PubMed ID: 14687488 [TBL] [Abstract][Full Text] [Related]
29. Prostate cancer antigen-1 as a potential novel marker for prostate cancer. Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469 [TBL] [Abstract][Full Text] [Related]
30. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer. Tang J; Wang Z; Li X; Li J; Shi H Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586 [TBL] [Abstract][Full Text] [Related]
31. Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia. Gandour-Edwards R; Mack PC; Devere-White RW; Gumerlock PH Prostate Cancer Prostatic Dis; 2004; 7(4):321-6. PubMed ID: 15314639 [TBL] [Abstract][Full Text] [Related]
32. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]. Liu BQ; Wu YD; Wei JX; Zhang T; Liu RL; Ma TX Zhonghua Nan Ke Xue; 2007 Nov; 13(11):997-1001. PubMed ID: 18077911 [TBL] [Abstract][Full Text] [Related]
33. p27KIP1-expression in human renal cell cancers: implications for clinical outcome. Anastasiadis AG; Calvo-Sanchez D; Franke KH; Ebert T; Heydthausen M; Schulz WA; Burchardt M; Gerharz CD Anticancer Res; 2003; 23(1A):217-21. PubMed ID: 12680216 [TBL] [Abstract][Full Text] [Related]
34. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. Alberti I; Barboro P; Barbesino M; Sanna P; Pisciotta L; Parodi S; Nicolò G; Boccardo F; Galli S; Patrone E; Balbi C J Cell Biochem; 2000 Sep; 79(3):471-85. PubMed ID: 10972984 [TBL] [Abstract][Full Text] [Related]
35. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116 [TBL] [Abstract][Full Text] [Related]
36. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue. Xu C; Zhou T; He M; Sun Y Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519 [TBL] [Abstract][Full Text] [Related]
37. [Expression of nucleosomal binding protein 1 in normal prostate benign prostate hyperplasia, and prostate cancer and significance thereof]. Song G; Zhou LQ; Weng M; He Q; He ZS; Hao JR; Pan BN; Na YQ Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1962-5. PubMed ID: 17064590 [TBL] [Abstract][Full Text] [Related]
38. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer. Zhigang Z; Wenlv S World J Surg Oncol; 2004 May; 2():13. PubMed ID: 15132743 [TBL] [Abstract][Full Text] [Related]
39. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia. Zhou T; Xu C; He M; Sun Y Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760 [TBL] [Abstract][Full Text] [Related]
40. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese. Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]